Literature DB >> 27145151

Structural Features Essential to the Antimicrobial Functions of Human SPLUNC1.

William G Walton1, Saira Ahmad2, Michael S Little1, Christine S K Kim2, Jean Tyrrell2, Qiao Lin3, Y Peter Di3, Robert Tarran2, Matthew R Redinbo1.   

Abstract

SPLUNC1 is an abundantly secreted innate immune protein in the mammalian respiratory tract that exerts bacteriostatic and antibiofilm effects, binds to lipopolysaccharide (LPS), and acts as a fluid-spreading surfactant. Here, we unravel the structural elements essential for the surfactant and antimicrobial functions of human SPLUNC1 (short palate lung nasal epithelial clone 1). A unique α-helix (α4) that extends from the body of SPLUNC1 is required for the bacteriostatic, surfactant, and LPS binding activities of this protein. Indeed, we find that mutation of just four leucine residues within this helical motif to alanine is sufficient to significantly inhibit the fluid spreading abilities of SPLUNC1, as well as its bacteriostatic actions against Gram-negative pathogens Burkholderia cenocepacia and Pseudomonas aeruginosa. Conformational flexibility in the body of SPLUNC1 is also involved in the bacteriostatic, surfactant, and LPS binding functions of the protein as revealed by disulfide mutants introduced into SPLUNC1. In addition, SPLUNC1 exerts antibiofilm effects against Gram-negative bacteria, although α4 is not involved in this activity. Interestingly, though, the introduction of surface electrostatic mutations away from α4 based on the unique dolphin SPLUNC1 sequence, and confirmed by crystal structure, is shown to impart antibiofilm activity against Staphylococcus aureus, the first SPLUNC1-dependent effect against a Gram-positive bacterium reported to date. Together, these data pinpoint SPLUNC1 structural motifs required for the antimicrobial and surfactant actions of this protective human protein.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27145151      PMCID: PMC4887393          DOI: 10.1021/acs.biochem.6b00271

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern.

Authors:  C D Bingle; L Bingle
Journal:  Biochim Biophys Acta       Date:  2000-10-02

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

Review 3.  Overview of surfactant replacement trials.

Authors:  Gautham K Suresh; Roger F Soll
Journal:  J Perinatol       Date:  2005-05       Impact factor: 2.521

4.  Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain.

Authors:  Hou-De Zhou; Gui-Yuan Li; Yi-Xin Yang; Xiao-Ling Li; Shou-Rong Sheng; Wen-Ling Zhang; Jin Zhao
Journal:  Mol Immunol       Date:  2005-12-20       Impact factor: 4.407

5.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set.

Authors:  N Sreerama; R W Woody
Journal:  Anal Biochem       Date:  2000-12-15       Impact factor: 3.365

6.  Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation.

Authors:  Hong Wei Chu; Jyoti Thaikoottathil; John G Rino; Gongyi Zhang; Qun Wu; Taylor Moss; Yosef Refaeli; Russell Bowler; Sally E Wenzel; Zhongzhou Chen; Jeffrey Zdunek; Rachel Breed; Ryan Young; Erin Allaire; Richard J Martin
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

7.  PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide.

Authors:  Bijar Ghafouri; Erik Kihlström; Christer Tagesson; Mats Lindahl
Journal:  Biochim Biophys Acta       Date:  2004-06-01

8.  Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus.

Authors:  Hou-De Zhou; Xiao-Ling Li; Gui-Yuan Li; Ming Zhou; Hua-Ying Liu; Yi-Xing Yang; Tan Deng; Jian Ma; Shou-Rong Sheng
Journal:  Mol Cell Biochem       Date:  2007-11-30       Impact factor: 3.396

9.  PLUNC is a novel airway surfactant protein with anti-biofilm activity.

Authors:  Lokesh Gakhar; Jennifer A Bartlett; Jon Penterman; Dario Mizrachi; Pradeep K Singh; Rama K Mallampalli; S Ramaswamy; Paul B McCray
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

10.  Latherin: a surfactant protein of horse sweat and saliva.

Authors:  Rhona E McDonald; Rachel I Fleming; John G Beeley; Douglas L Bovell; Jian R Lu; Xiubo Zhao; Alan Cooper; Malcolm W Kennedy
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

View more
  22 in total

1.  BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation.

Authors:  Clemente J Britto; Naiqian Niu; Sara Khanal; Luai Huleihel; Jose D Herazo-Maya; Alison Thompson; Maor Sauler; Martin D Slade; Lokesh Sharma; Charles S Dela Cruz; Naftali Kaminski; Lauren E Cohn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

2.  Thickness of the airway surface liquid layer in the lung is affected in cystic fibrosis by compromised synergistic regulation of the ENaC ion channel.

Authors:  Daniel V Olivença; Luis L Fonseca; Eberhard O Voit; Francisco R Pinto
Journal:  J R Soc Interface       Date:  2019-08-28       Impact factor: 4.118

3.  SPLUNC1 is a negative regulator of the Orai1 Ca2+ channel.

Authors:  Tongde Wu; Alexandra S Goriounova; Erin N Worthington; Joe A Wrennall; Arunava Ghosh; Saira Ahmad; M Flori Sassano; Robert Tarran
Journal:  Physiol Rep       Date:  2022-05

4.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease.

Authors:  Shawn T Terryah; Robert C Fellner; Saira Ahmad; Patrick J Moore; Boris Reidel; Juliana I Sesma; Christine S Kim; Alaina L Garland; David W Scott; Juan R Sabater; Jerome Carpenter; Scott H Randell; Mehmet Kesimer; William M Abraham; William J Arendshorst; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-05       Impact factor: 5.464

6.  Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration.

Authors:  Patrick J Moore; Boris Reidel; Arunava Ghosh; Juliana Sesma; Mehmet Kesimer; Robert Tarran
Journal:  FASEB J       Date:  2018-06-11       Impact factor: 5.191

7.  ENaC regulation by phospholipids and DGK explained through mathematical modeling.

Authors:  Daniel V Olivença; Eberhard O Voit; Francisco R Pinto
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

8.  Crystal structure of the mouse innate immunity factor bacterial permeability-increasing family member A1.

Authors:  Michael S Little; Matthew R Redinbo
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-04-16       Impact factor: 1.056

9.  SPLUNC1 is an allosteric modulator of the epithelial sodium channel.

Authors:  Christine Seulki Kim; Saira Ahmad; Tongde Wu; William G Walton; Matthew R Redinbo; Robert Tarran
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

10.  SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Authors:  Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 33.795

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.